News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,032 Results
Type
Article (12427)
Company Profile (67)
Press Release (254531)
Multimedia
Podcasts (24)
Webinars (8)
Section
Business (74697)
Career Advice (433)
Deals (14092)
Drug Delivery (38)
Drug Development (36834)
Employer Resources (31)
FDA (7177)
Job Trends (5410)
News (133617)
Policy (12126)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (834)
Academic (1)
Accelerated approval (14)
Adcomms (7)
Allergies (59)
Alliances (18897)
ALS (88)
Alzheimer's disease (642)
Antibody-drug conjugate (ADC) (167)
Approvals (7478)
Artificial intelligence (168)
Autoimmune disease (67)
Automation (13)
Bankruptcy (77)
Best Places to Work (4408)
BIOSECURE Act (12)
Biosimilars (72)
Biotechnology (41)
Bladder cancer (76)
Brain cancer (21)
Breast cancer (317)
Cancer (2356)
Cardiovascular disease (210)
Career advice (356)
Career pathing (13)
CAR-T (124)
CDC (10)
Cell therapy (321)
Cervical cancer (14)
Clinical research (32509)
Collaboration (738)
Company closure (1)
Compensation (1110)
Complete response letters (17)
COVID-19 (965)
CRISPR (38)
C-suite (345)
Cystic fibrosis (58)
Data (3201)
Decentralized trials (2)
Denatured (5)
Depression (38)
Diabetes (268)
Diagnostics (2284)
Digital health (17)
Diversity (1)
Diversity, equity & inclusion (11)
Drug discovery (107)
Drug pricing (50)
Drug shortages (6)
Duchenne muscular dystrophy (87)
Earnings (33510)
Editorial (16)
Employer branding (5)
Employer resources (32)
Events (38367)
Executive appointments (375)
FDA (8711)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (2)
Frontotemporal dementia (10)
Funding (620)
Gene editing (84)
Generative AI (14)
Gene therapy (235)
GLP-1 (452)
Government (1531)
Grass and pollen (2)
Guidances (232)
Healthcare (6698)
HIV (27)
Huntington's disease (21)
IgA nephropathy (47)
Immunology and inflammation (85)
Immuno-oncology (25)
Indications (59)
Infectious disease (1083)
Inflammatory bowel disease (83)
Inflation Reduction Act (3)
Influenza (57)
Intellectual property (85)
Interviews (66)
IPO (7894)
IRA (19)
Job creations (1236)
Job search strategy (311)
JPM (30)
Kidney cancer (7)
Labor market (22)
Layoffs (237)
Leadership (16)
Legal (2361)
Liver cancer (40)
Longevity (4)
Lung cancer (386)
Lymphoma (286)
Machine learning (14)
Management (12)
Manufacturing (393)
MASH (77)
Medical device (4253)
Medtech (4270)
Mergers & acquisitions (6713)
Metabolic disorders (560)
Multiple sclerosis (51)
NASH (7)
Neurodegenerative disease (130)
Neuropsychiatric disorders (35)
Neuroscience (1115)
NextGen: Class of 2026 (1965)
Non-profit (1817)
Now hiring (23)
Obesity (211)
Opinion (114)
Ovarian cancer (75)
Pain (64)
Pancreatic cancer (93)
Parkinson's disease (109)
Partnered (14)
Patents (153)
Patient recruitment (188)
Peanut (17)
People (21428)
Pharmaceutical (16)
Pharmacy benefit managers (9)
Phase 1 (9239)
Phase 2 (13917)
Phase 3 (11770)
Pipeline (2911)
Policy (93)
Postmarket research (1514)
Preclinical (3853)
Press Release (43)
Prostate cancer (98)
Psychedelics (15)
Radiopharmaceuticals (130)
Rare diseases (360)
Real estate (2325)
Recruiting (10)
Regulatory (10214)
Reports (15)
Research institute (854)
Resumes & cover letters (62)
Rett syndrome (13)
RNA editing (4)
RSV (31)
Schizophrenia (61)
Series A (93)
Series B (62)
Service/supplier (6)
Sickle cell disease (43)
Special edition (8)
Spinal muscular atrophy (41)
Sponsored (13)
Startups (1322)
State (1)
Stomach cancer (4)
Supply chain (32)
Tariffs (33)
The Weekly (19)
Vaccines (380)
Venture capital (43)
Weight loss (116)
Women's health (26)
Worklife (2)
Date
Last 7 days (261)
Last 30 days (910)
Last 365 days (13808)
2026 (1214)
2025 (13892)
2024 (15191)
2023 (16754)
2022 (22014)
2021 (22709)
2020 (20194)
2019 (16785)
2018 (12561)
2017 (11937)
2016 (10555)
2015 (12166)
2014 (8906)
2013 (7200)
2012 (8149)
2011 (9414)
2010 (9175)
Location
Africa (212)
Alabama (29)
Alaska (2)
Arizona (69)
Arkansas (1)
Asia (17950)
Australia (2390)
California (4778)
Canada (1367)
China (712)
Colorado (168)
Connecticut (232)
Delaware (217)
Europe (41378)
Florida (648)
Georgia (147)
Hawaii (2)
Idaho (16)
Illinois (332)
India (31)
Indiana (262)
Iowa (11)
Japan (268)
Kansas (47)
Kentucky (22)
Louisiana (14)
Maine (25)
Maryland (573)
Massachusetts (3573)
Michigan (110)
Minnesota (182)
Mississippi (3)
Missouri (58)
Montana (8)
Nebraska (12)
Nevada (44)
New Hampshire (8)
New Jersey (1510)
New Mexico (7)
New York (1199)
North Carolina (1454)
North Dakota (5)
Northern California (2445)
Ohio (156)
Oklahoma (8)
Oregon (11)
Pennsylvania (864)
Puerto Rico (5)
Rhode Island (39)
South America (403)
South Carolina (55)
Southern California (1854)
Tennessee (31)
Texas (640)
United States (17536)
Utah (118)
Virginia (81)
Washington D.C. (56)
Washington State (351)
West Virginia (2)
Wisconsin (48)
Wyoming (1)
267,032 Results for "c r bard".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
/C O R R E C T I O N -- Chamber Cardio/
February 5, 2026
·
3 min read
Press Releases
/C O R R E C T I O N -- Privo Technologies/
January 26, 2026
·
2 min read
Press Releases
/C O R R E C T I O N -- Orasis Pharmaceuticals/
January 28, 2026
·
8 min read
Press Releases
/C O R R E C T I O N from source -- argenx Canada Inc./
November 6, 2025
·
7 min read
Press Releases
/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./
October 21, 2025
·
8 min read
Press Releases
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
- Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthma - Positive opinion from the European Patent Office strengthens patent protection of ATP-R13 - Progress significantly enhances the strategic attractiveness of ATP-R13 as a broadly applicable, disease-modifying therapy across multiple allergic indications
January 20, 2026
·
1 min read
Drug Pricing
Opinion: Pricing Transparency Is Coming to the Pharma Industry
Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.
February 2, 2026
·
5 min read
·
Joshua R. Mansbach
Press Releases
Theralase(R) Investor Conference Call Reminder
Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete Response
November 17, 2025
·
5 min read
Drug pricing
Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C. A similar dynamic is now playing out between Eli Lilly and Novo Nordisk in the obesity space, with some key differences.
November 18, 2025
·
7 min read
·
Annalee Armstrong
Business
Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent
The Washington, D.C.–Baltimore area ranks in the top six for life sciences R&D and manufacturing talent, according to a CBRE report. The Maryland Department of Commerce’s director of life sciences discusses the workforce and how the state is adapting to changing needs.
July 24, 2025
·
4 min read
·
Angela Gabriel
1 of 26,704
Next
